Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06005272
Other study ID # 314658
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date September 1, 2023
Est. completion date March 31, 2027

Study information

Verified date November 2023
Source University of Manchester
Contact Alexander E Heazell, PhD
Phone +441612646484
Email alexander.heazell@manchester.ac.uk
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This project aims to identify factors linked to pregnancy losses occurring between 20 and 28 weeks of pregnancy that can be modified by changing mother's behaviour or healthcare provision. The death of a child before birth (also called stillbirth or miscarriage) has enduring psychological, social and economic effects for women, their families and wider society. In 2015, the stillbirth rate in the UK was higher than comparable countries. The UK government has committed to reduce stillbirths by 50% by 2025. Presently, stillbirths after 28 weeks of pregnancy have reduced by 16% but there has been no change in losses between 20 and 28 weeks of pregnancy with 1,600 losses estimated to occur at this stage of pregnancy each year. Identification of modifiable causes of stillbirth was identified as a research priority by the Stillbirth Priority Setting Partnership which involved over 1,000 participants, one third of whom were bereaved parents. The investigators previously completed a study of 291 women who had a late stillbirth (after 28 weeks of pregnancy) and 733 women who had a live baby in 41 maternity units in the UK. This study identified factors linked to stillbirth which can be changed including the position women go to sleep in, cigarette smoking and caffeine consumption. In addition, the investigators previously found changes in mother's perception of baby's movements, whether women had tests for diabetes or whether women were exposed to domestic violence or stressful situations. These factors can be addressed by different care in pregnancy. Information from this study has been included in national and international guidelines that aim to reduce stillbirth. The investigators will use the same study type to identify factors associated with pregnancy loss between 20 and 28 weeks of pregnancy (early stillbirth). The investigators have asked parents who have experienced the death of a baby at these stages of pregnancy about the design of the study, the questions that would be asked and how best to approach bereaved parents. This led us to include miscarriages from 20-22 weeks of pregnancy that are not usually "counted" in UK stillbirth statistics. The investigators will need 316 women with stillbirth between 20 and 28 weeks of pregnancy and 632 women with an ongoing live pregnancy to participate in the study. All women will complete a questionnaire about themselves, their diet, behaviours and sleep, their baby's movements and pregnancy care. The investigators will compare information between women who have early stillbirth and those who have a live birth to identify factors associated with stillbirth at less than 28 weeks of pregnancy. The study findings will be disseminated in collaboration with patient organisations using effective ways to reach pregnant women. The investigators anticipate the findings from this study will be included in clinical practice guidelines and rapidly translated into antenatal care.


Description:

Research question What are the modifiable risk factors for early stillbirth (between 20-28 weeks' gestation)? Background The NHS Long Term Plan sets a goal to reduce stillbirth by 50% by 2025 (from 2013 rates). Some progress has been made with reduction of stillbirths in late pregnancy (≥28 weeks' gestation). However, rates of early stillbirth (<28 weeks' gestation) remain intractable and new initiatives to reduce early stillbirth rates are needed to achieve this goal. Our previous study (MiNESS) informed about modifiable risk factors for stillbirth ≥28 weeks' gestation and were incorporated into national guidance to reduce stillbirth. However, there is an evidence gap related to modifiable risk factors for early stillbirth. Aims and Objectives The overall aim of the study is to 1. Identify modifiable risk factors for early stillbirth that are amenable to public health campaigns or adaptation of antenatal care. The study will specifically, 2. Confirm or refute whether modifiable behavioural factors associated with late stillbirth are also independently associated with early stillbirth. 3. Explore interactions between maternal characteristics (especially those relating to health inequalities including ethnicity and socioeconomic deprivation), fetal factors (including fetal growth restriction, reduced fetal movements) and early stillbirth risk. 4. Determine differences in risk factor profiles by cause of death. Methods This study uses a case-control design based upon that successfully used in the MiNESS study. The eligible population are women with a non-anomalous singleton pregnancy. "Cases" are women who have a stillbirth between 20+0 and 27+6 weeks' gestation and "Controls" are women who have an ongoing viable pregnancy at an equivalent gestational age. Controls will be randomly selected from participating maternity units' booking list at the appropriate week of pregnancy to match the unit's historic distribution of early stillbirths in a 1:2 (case:control) ratio. The study will recruit 316 cases and 632 controls; this gives 80% power to detect associations with an odds ratio ≥1.5. Participants will complete a researcher-administered questionnaire and relevant data will be extracted from medical records. Cases will be approached before hospital discharge, aiming to complete the research interview where possible within 3 weeks. Unadjusted associations between early stillbirth and each exposure will be calculated. Logistic regression models, adjusted for confounding variables, will consider multiple exposures in relation to early stillbirth.


Recruitment information / eligibility

Status Recruiting
Enrollment 948
Est. completion date March 31, 2027
Est. primary completion date March 31, 2026
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 16 Years to 50 Years
Eligibility Cases - Bereaved mothers/parents who have recently birthed a singleton baby who died before/during or immediately after labour between 20 and 28 weeks of pregnancy. - Baby has no evidence of congenital anomaly - Able to give written informed consent Controls - Pregnant women/people with an ongoing pregnancy (at the target gestation) receiving antenatal care from a participating maternity unit, at a gestation matched to the distribution of stillbirths between 20 to 28 weeks of pregnancy in the same unit - Baby has no evidence of congenital anomaly - Able to give written informed consent

Study Design


Intervention

Other:
Questionnaire
Interviewer assisted completion of questionnaire.

Locations

Country Name City State
United Kingdom Manchester University NHS Foundation Trust Manchester

Sponsors (4)

Lead Sponsor Collaborator
University of Manchester University of Birmingham, University of Leeds, University of Leicester

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Maternal sleep position during pregnancy Self-reported sleep position The night prior to questionnaire or the night prior to pregnancy loss
Primary Duration of sleep during pregnancy Self-reported duration of sleep The night prior to questionnaire or the night prior to pregnancy loss
Primary Presence of snoring during pregnancy Self-reported presence of snoring during pregnancy The night prior to questionnaire or the night prior to pregnancy loss
Secondary Maternal perception of fetal movement frequency Self-reported perception of frequency of fetal activity Two-weeks prior to questionnaire or two weeks prior to pregnancy loss
Secondary Maternal perception of fetal movement strength Self-reported perception of strength of fetal activity Two-weeks prior to questionnaire or two weeks prior to pregnancy loss
Secondary Maternal caffeine exposure Self-reported intake of caffeinated drinks One month prior to questionnaire
Secondary Engagement with antenatal care Number of appointments with health professionals Duration of Pregnancy (from booking to the time interview)
Secondary Exposure to Intimate Partner Violence Self-reported exposure to abusive behaviour using standardised questions Duration of Pregnancy (from booking to the time interview)
See also
  Status Clinical Trial Phase
Completed NCT04598165 - Mobile WACh NEO: Mobile Solutions for Neonatal Health and Maternal Support N/A
Recruiting NCT03662178 - Investigating the Structured Use of Ultrasound Scanning for Fetal Growth
Completed NCT03729089 - Third Trimester Modified Biophysical Profile Scan for Predicting Fetal Outcome. N/A
Completed NCT05369806 - Leveraging Interactive Text Messaging to Monitor and Support Maternal Health in Kenya N/A
Recruiting NCT03220750 - University Hospital Advanced Age Pregnant Cohort N/A
Recruiting NCT04766866 - sFlt1/PlGF and Planned Delivery to Prevent Preeclampsia at Term. N/A
Recruiting NCT05640063 - Evaluation of Enhanced Delivery and Newborn Kit N/A
Completed NCT06169423 - Simulation of Perinatal Grief. (SPG) N/A
Withdrawn NCT03996317 - Maternal Hyperoxygenation for Intrapartum Fetal Heart Rate Tracing Abnormalities N/A
Recruiting NCT06273007 - Improving Intrapartum Care for Saving Life at Birth in Ethiopia Through PartoMa Approach N/A
Completed NCT03213509 - Verbal Autopsy of Maternal Deaths, Stillbirths, and Neonatal Deaths in BetterBirth
Recruiting NCT05187897 - CHV-NEO: Community-based Digital Communication to Support Neonatal Health N/A
Recruiting NCT04356326 - Chronic Hypertension and Acetyl Salicylic Acid in Pregnancy Phase 3
Not yet recruiting NCT05223140 - Optimal Time Intervals for Vaginal Breech Births: A Multi-Site Case-Control Study
Recruiting NCT06125860 - BEP Targeting Strategies in Ethiopia N/A